Navin Fluorine International Limited (NFIL) belongs to a reputed industrial house of the Arvind Mafatlal Group. The company owns one of India’s largest integrated flurochemicals complexes. It produces a wide range of flurochemicals in the bulk and speciality segment. It is a public limited company, incorporated under the provisions of the Companies Act, 1956. Its shares are listed on the Bombay and National stock exchanges. The Company belongs to the Padmanabh Mafatlal Group, with a legacy of business operations since 1967, having one of the largest integrated fluorochemicals complex in India.
Business area of the company
The Company primarily focuses on fluorine chemistry - producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers Contract Research and Manufacturing Services. Its manufacturing facilities are located at Surat in Gujarat and Dewas in Madhya Pradesh.
Refrigeration: NFIL introduced refrigerants into India in 1967 by commissioning its manufacturing plant at Surat, Gujarat, Western India. It is backward integrated into the manufacture of critical intermediates namely sulphuric and hydrofluoric acid which are precursors to its Mafron brand of refrigerants. With over forty years of leadership in fluorine chemistry and refrigerant science, NFIL offers safe, high performance and high quality refrigerants for various refrigeration and air conditioning applications.
Inorganic Fluorides: NFIL set up an integrated fluorochemicals complex at Surat in 1967. It has one of the largest Anhydrous Hydrofluoric (AHF) and Aqueous Hydrofluoric acid manufacturing capacities in India. AHF is used for captive manufacture of various inorganic fluorides. NFIL has a long and rich experience in manufacturing various inorganic fluorides with capacity, flexibility and experienced work force. NFIL has the ability to develop products as per customer’s need. NFIL enjoys a respectable market share and excellent relationship with large global consumers of inorganic fluorides. Additional investments are planned to enhance capacities and widen the product range.
Specialty Fluorochemicals: The Company’s expertise, built through decades of experience in fluorine chemistry, coupled with state of art manufacturing infrastructure enables the company to produce a wide range of value added Specialty fluoro intermediates in large quantities in a safe and responsible manner. NFIL has dedicated multipurpose plants (MPP) to process multi step products and intermediates which are high in the value chain. It has capabilities to handle complex chemistries and deliver high quality products in all forms. NFIL is one of the leading high quality producers of Boron trifluoride gas and it’s adducts.
CRAMS: NFIL is in the business of offering Contract Research and Manufacturing Services (CRAMS) for custom chemical syntheses of fluorinated compounds for the pharmaceuticals, agro chemicals and speciality chemicals industries.
During the year, the Company’s facility at Surat received various HSE awards and recognitions and letters of appreciation from the Government of Gujarat, National Safety Council, etc. The Company run several in-house HSE awareness programmes at all its locations.
The Surat plant of the Company has been awarded with the “Silver Trophy” and a certificate by National Safety Council of India for commendable Occupational Safety & Health performance. It is the only manufacturing unit in the catagory in Gujarat to get this award during 2015-16, which exemplifies the Company’s commitment towards safety.
During the year, the Company has been declared a Winner in the Category of “Operational Excellence in Safety” for its Responsible Care Initiatives in Distribution at the Manufacturing & Supply Chain Summit Awards 2017; which exemplifies the Company’s commitment towards safety.
The Surat & Dewas Plants of the Company have secured Certificates of Appreciation for Safety in Operations from the National Safety Council during the year.
During the year, the Company has been conferred two awards by the Indian Chemical Council (ICC). One was the ICC award for “Excellence in Human Resource Management in Chemical Industry” for the year 2017 and the second was Certificate of Merit for the “Best Compliant Company for the Distribution Code under Responsible Care” for the year 2017.
Apart from these, the Company also received the “CSR Excellence Award 2018” for Health and Sanitation in Gujarat CSR Summit - 2018.
During the year, the Company was awarded by ET NOW as “Emerging Company of the Year”.
It also received an award from the Indian Chemical Council (ICC) for “The Best Compliant Company for Emergency Response Code under Responsible Care” for the year 2018.
1967: Establishment of the First Integrated Fluorochemicals Complex in South East Asia (excluding Japan) to produce HF, refrigerant gases and a range of inorganic fluorides at Surat, Western India
1969: Commencement of commercial production of refrigerant gases
1978: Facility was set up at Dewas to produce Alkylated Anilines and Toluidine’s
1982: Capacity expansion at Surat for Smelter Fluorides and AIF3
1990: CFC 113 plant commissioned at Surat
1999: Commencement of Organic and Inorganic Specialty Fluoride production at Surat
2000: Commencement of Fluorobenzene and Benzotrifluoride series production at Surat
2001: Set up first large scale plant in South East Asia for production of Boron Trifluoride Gas at Surat
2003: Capacity expansion of Specialty Organic Fluorides at Surat
2004: Commissioned Trifluoroacetic acid plant at Surat
2005: Commissioned Trifluoroethanol plant at Surat
2006: Capacity expansion of Boron Trifluoride Gas
2007: Commissioned CDM plant at Surat
2008: Inauguration of New R & D Centre – Navin Research Innovation Centre (NRIC) at Surat
2009: Start-up of Pilot Plant for scale up of research and development molecules.
2010: Established Multi-purpose plant and CRO at Surat
2011: Capacity expansion of BF3 at Surat
2011: Acquisition of Land at Dahej for further expansion
2011: Acquisition of Manchester Organics Limited, UK
2011: Commissioning of cGMP pilot plant at Dewas
2013: Expansion of multi-purpose plant at Surat
2015: CRAMS cGMP multi-purpose plant
2017-18: Invested in R&D and capacity growth to address growing demand
2018-19: Board approved the capex for creating additional cGMP capacity and associated infrastructure
2019-20: The Company ventured into commercialisation of a number of molecules under evaluation and reported superior growth in existing products